Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma

MLA

Yiran Tao, et al. “Targeting of DDR1 with Antibody‐drug Conjugates Has Antitumor Effects in a Mouse Model of Colon Carcinoma.” Molecular Oncology, vol. 13, no. 9, Sept. 2019, pp. 1855–73. EBSCOhost, https://doi.org/10.1002/1878-0261.12520.

APA

Yiran Tao, Ruixue Wang, Qinhuai Lai, Mengdan Wu, Yuxi Wang, Xiaohua Jiang, Lishi Zeng, Shijie Zhou, Zhongping Li, Tinghan Yang, Yuqin Yao, Yangping Wu, Lin Yu, Yuyin Fu, Weirong Lai, Yujia Peng, Ying Lu, Zhixiong Zhang, Cuiyu Guo, … Jinliang Yang. (2019). Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma. Molecular Oncology, 13(9), 1855–1873. https://doi.org/10.1002/1878-0261.12520

Chicago

Yiran Tao, Ruixue Wang, Qinhuai Lai, Mengdan Wu, Yuxi Wang, Xiaohua Jiang, Lishi Zeng, et al. 2019. “Targeting of DDR1 with Antibody‐drug Conjugates Has Antitumor Effects in a Mouse Model of Colon Carcinoma.” Molecular Oncology 13 (9): 1855–73. doi:10.1002/1878-0261.12520.